High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types-Reference-Cited by-同舟云学术

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Published:2021-05 Issue:5 Volume:32 Page:661-672
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

McGrail D.J.,Pilié P.G.,Rashid N.U.,Voorwerk L.,Slagter M.,Kok M.,Jonasch E.,Khasraw M.,Heimberger A.B.,Lim B.,Ueno N.T.,Litton J.K.,Ferrarotto R.,Chang J.T.,Moulder S.L.,Lin S.-Y.

Funder

Kidney Cancer Association

Prostate Cancer Foundation

Cancer Prevention and Research Institute of Texas

Susan G Komen for the Cure

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference60 articles.

1. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov,2018

2. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic;Chan;Ann Oncol,2019

3. Tumor neoantigens: building a framework for personalized cancer immunotherapy;Gubin;J Clin Invest,2015

4. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy;Cristescu;Science,2018

5. The repertoire of mutational signatures in human cancer;Alexandrov;Nature,2020

Cited by 696 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration;Current Gene Therapy;2025-04

2. Liposomes-enabled cancer chemoimmunotherapy;Biomaterials;2025-02

3. Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder;Modern Pathology;2024-11

4. Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes;Gynecologic Oncology;2024-10

5. Asiaticoside modulates human NK cell functional fate by mediating metabolic flexibility in the tumor microenvironment;Phytomedicine;2024-10